跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
JOENJA
Authorized
STANDARD
JOENJA
Pharming Technologies B.V.
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
e9814a8b61ae8344
Company
Pharming Technologies B.V.
Type
Standard
Approval Details
Approval Id
e9814a8b61ae8344
Drug Approval Canada Name
JOENJA
Product Name
JOENJA
Status
Approved
Status Date
2026-07-08
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION RECOMMENDED
Atc Original
L03AX22 LENIOLISIB
Aig Number
0168475001
Company Name
Pharming Technologies B.V.
Company Address
Darwinweg 24 Leiden Netherlands 2333 CR
Company Detail Path
/organization/pharming-technologies-b-v
Company Information
Pharmaceutical Company Name
Pharming Technologies B.V.
Country Name
Netherlands
Province Name
zuid-holland,country_nl
City Name
leiden,zuid-holland,country_nl
Address
Vondellaan 47
Active Ingredients
LENIOLISIB (LENIOLISIB PHOSPHATE)
70 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
e9814a8b61ae8344
Type
Standard
Back to Health Canada Approvals
JOENJA - Health Canada Drug Approval Details